Hyperphosphataemia and Eosinophil count increased

Summary:

Eosinophil count increased is found among people with Hyperphosphataemia, especially for people who are male, 60+ old.

The study analyzes which people have Eosinophil count increased with Hyperphosphataemia. It is created by eHealthMe based on reports of 11 people who have Hyperphosphataemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hyperphosphataemia?

Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood) is found to be associated with 429 drugs and 377 conditions by eHealthMe. Check the latest studies of Hyperphosphataemia.

What is Eosinophil count increased?

Eosinophil count increased is found to be associated with 768 drugs and 1,130 conditions by eHealthMe. Check the latest studies of Eosinophil count increased.

On Aug, 10, 2026

11 people who have Hyperphosphataemia and Eosinophil Count Increased are studied.

Would you have Eosinophil count increased when you have Hyperphosphataemia?

Gender of people who have Hyperphosphataemia and experienced Eosinophil Count Increased *:

female: 45.45 %
male: 54.55 %

Age of people who have Hyperphosphataemia and experienced Eosinophil Count Increased *:

Common co-existing conditions for these people *:

Hyperparathyroidism Secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary): 6 people, 54.55%
High Blood Pressure: 5 people, 45.45%
Insomnia (sleeplessness): 5 people, 45.45%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 36.36%
Nephrogenic Anaemia (anaemia due to kidney disease): 4 people, 36.36%
Gastritis - Chronic (long lasting inflammation of stomach): 3 people, 27.27%
Thyroiditis Chronic (long lasting inflammation of thyroid gland): 3 people, 27.27%
Indigestion: 3 people, 27.27%
Type 2 Diabetes: 3 people, 27.27%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 27.27%

Common drugs taken by these people *:

Renagel: 5 people, 45.45%
Plavix: 3 people, 27.27%
Evista: 3 people, 27.27%
Velphoro: 2 people, 18.18%
Fosrenol: 2 people, 18.18%
Meropenem: 1 person, 9.09%
Adalat Cc: 1 person, 9.09%
Amlodipine: 1 person, 9.09%
Cinacalcet Hydrochloride: 1 person, 9.09%
Crestor: 1 person, 9.09%

Common symptoms for these people *:

Pneumonia: 3 people, 27.27%
Cerebral Haemorrhage (bleeding within the brain): 3 people, 27.27%
Renal Haemorrhage (bleeding from kidney): 2 people, 18.18%
High Blood Pressure: 2 people, 18.18%
White Blood Cell Count Decreased: 1 person, 9.09%
Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 9.09%
Thrombocytopenia (decrease of platelets in blood): 1 person, 9.09%
Rashes (redness): 1 person, 9.09%
Procedural Hypertension: 1 person, 9.09%
Hypotension (abnormally low blood pressure): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Eosinophil count increased?

- Check whether Eosinophil count increased is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Eosinophil count increased and Hyperphosphataemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.